Baidu
map

罕见鼻腔代谢性骨病患者获成功诊治

2014-02-12 佚名 不详

近日,广西壮族自治区人民医院多科联合,成功诊治了一位罕见鼻腔鼻窦血管球周皮细胞瘤相关低磷软骨化病患者,被疾病折磨了4年之久的患者经实施鼻内镜微创手术后康复出院。 患者杨某是南宁市人,46岁,自2009年8月起无明显诱因出现胸部疼痛伴左侧鼻塞,逐渐加重至全身疼痛并伴乏力,曾到南宁市多家医院诊治,但效果均不好,后来症状逐渐加重导致行走困难。2013年年底,他到广西壮族自治区人民医院内分泌代谢科就诊,

近日,广西壮族自治区人民医院多科联合,成功诊治了一位罕见鼻腔鼻窦血管球周皮细胞瘤相关低磷软骨化病患者,被疾病折磨了4年之久的患者经实施鼻内镜微创手术后康复出院。

患者杨某是南宁市人,46岁,自2009年8月起无明显诱因出现胸部疼痛伴左侧鼻塞,逐渐加重至全身疼痛并伴乏力,曾到南宁市多家医院诊治,但效果均不好,后来症状逐渐加重导致行走困难。2013年年底,他到广西壮族自治区人民医院内分泌代谢科就诊,经骨密度测定为骨质疏松。该院内分泌代谢科主任颜晓东组织科内疑难病例讨论,并请耳鼻咽喉科主治医师王涛会诊。根据患者病情,王涛建议转耳鼻咽喉科手术治疗。在做好充分术前准备后,王涛等医生为患者实施了鼻内镜微创手术,手术很成功。术后把肿瘤送病理科做病理检查,病理科主任莫祥兰博士组织科内疑难病理讨论,最终确定为鼻腔鼻窦血管球周皮细胞瘤相关低磷软骨化病。术后,患者的骨痛、乏力、行走困难等相关临床症状逐渐消失,血磷及维生素D也逐渐恢复正常。

专家介绍,肿瘤相关性低磷软骨病(TIO)是一种非常罕见的代谢性骨病,迄今国际上报道不超过200例。引起TIO的肿瘤大多为良性、体积较小、起病隐匿、生长缓慢,最多见于四肢,其次为头面部,发生于鼻腔鼻窦的间叶组织肿瘤极其罕见。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1989569, encodeId=8da31989569d8, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Jul 10 21:25:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465813, encodeId=3173146581369, content=<a href='/topic/show?id=736b103508c6' target=_blank style='color:#2F92EE;'>#鼻腔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103508, encryptionId=736b103508c6, topicName=鼻腔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=224e6763385, createdName=mnda, createdTime=Fri Feb 14 00:25:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467041, encodeId=17e0146e041c4, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri Feb 14 00:25:00 CST 2014, time=2014-02-14, status=1, ipAttribution=)]
    2014-07-10 sodoo
  2. [GetPortalCommentsPageByObjectIdResponse(id=1989569, encodeId=8da31989569d8, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Jul 10 21:25:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465813, encodeId=3173146581369, content=<a href='/topic/show?id=736b103508c6' target=_blank style='color:#2F92EE;'>#鼻腔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103508, encryptionId=736b103508c6, topicName=鼻腔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=224e6763385, createdName=mnda, createdTime=Fri Feb 14 00:25:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467041, encodeId=17e0146e041c4, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri Feb 14 00:25:00 CST 2014, time=2014-02-14, status=1, ipAttribution=)]
    2014-02-14 mnda
  3. [GetPortalCommentsPageByObjectIdResponse(id=1989569, encodeId=8da31989569d8, content=<a href='/topic/show?id=5e202543023' target=_blank style='color:#2F92EE;'>#代谢性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25430, encryptionId=5e202543023, topicName=代谢性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6cc1239, createdName=sodoo, createdTime=Thu Jul 10 21:25:00 CST 2014, time=2014-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465813, encodeId=3173146581369, content=<a href='/topic/show?id=736b103508c6' target=_blank style='color:#2F92EE;'>#鼻腔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103508, encryptionId=736b103508c6, topicName=鼻腔)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=224e6763385, createdName=mnda, createdTime=Fri Feb 14 00:25:00 CST 2014, time=2014-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467041, encodeId=17e0146e041c4, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri Feb 14 00:25:00 CST 2014, time=2014-02-14, status=1, ipAttribution=)]
    2014-02-14 heli0118
Baidu
map
Baidu
map
Baidu
map